Cryoablation for the Treatment of Metastatic Cancer
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
This interventional trial studies the effectiveness of adding cryoablation treatment in
patients who are receiving standard of care immunotherapy to treat cancer that is has spread
to other parts of the body (metastatic). Cryoablation uses a probe that freezes the tissue
around the tumor to try to kill the cancer cells. Using cryoablation to treat cancerous
lesions may help to kill the cancer cells.